These results suggest that inhibition of the TLR4-MyD88-NFκB-mediated inflammatory response can down-regulate the expression of TLR4 mRNA and protein, thereby improving hepatic fibrosis (91) (Table 1). This evidence concerns the gene TLR4 and Hepatic fibrosis.